Evidence map›Paper›PMID 34798326›Full record

Observational studyPublic health2021

Psychotropic medications sales during COVID-19 outbreak in Italy changed according to the pandemic phases and related lockdowns.

B Farina, C Massullo, E De Rossi, G A Carbone, R Serraino, C Imperatori

Abstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

B FarinaCognitive and Clinical Psychology Laboratory, Department of Human Sciences, European University of Rome, Italy.
C MassulloCognitive and Clinical Psychology Laboratory, Department of Human Sciences, European University of Rome, Italy.
E De RossiCognitive and Clinical Psychology Laboratory, Department of Human Sciences, European University of Rome, Italy.
G A CarboneCognitive and Clinical Psychology Laboratory, Department of Human Sciences, European University of Rome, Italy.
R SerrainoPharma Experience, Rome, Italy.
C ImperatoriCognitive and Clinical Psychology Laboratory, Department of Human Sciences, European University of Rome, Italy. Electronic address: claudio.imperatori@unier.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesWe have investigated the psychotropic medications sales (i.e. benzodiazepines, mood stabilisers and selective serotonin reuptake inhibitors) during the COVID-19 pandemic in the period from March 2020 to February 2021 compared with the same period in the preceding year. STUDY

designThis was a retrospective and observational study.

methodsData were obtained from five pharmacies located in a working-class zone populated by approximately 150,000 people in the urban area of Rome (Italy).

resultsA general slight increase in psychotropic medications sales was observed during the whole pandemic period compared with the previous year.

conclusionOur data showed that (1) the percentage of sales seems to vary according to the pandemic phases and related lockdowns and (2) the sales differ between the classes of medications considered.

Indexed as

COVID-19PandemicsCommunicable Disease ControlDisease OutbreaksHumansItalyPsychotropic DrugsRetrospective StudiesSARS-CoV-2Psychotropic DrugsCOVID-19Mental healthPsychotropic medications

Identifiers

PMID34798326
PMCPMC8598264

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.